Article
Detection of alpha-1 antitrypsin deficiency: the past, present and future
19 Apr 2020
Abstract excerpt
BACKGROUND: Most patients with alpha-1 antitrypsin deficiency remain undiagnosed and therefore do not benefit from current therapies or become eligible for research studies of new treatments under development. Improving the detection rate for AATD is therefore a high priority for the Alpha-1 Foundation. A workshop was held on June 23, 2019 in Orlando, Florida during which stakeholders from the research,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
